NACL Ind hits 5% upper circuit as board to consider fund raising on Dec 1

The buying on the counter came after the company announced it would consider raising funds in a meeting on December 1, 2025

NACL Industries share price
Photo: Shutterstock
SI Reporter Mumbai
2 min read Last Updated : Nov 27 2025 | 11:54 AM IST

Don't want to miss the best from Business Standard?

NACL Industries shares were locked in a 5 per cent upper circuit on the BSE, at ₹196.1 per share. The buying on the counter came after the company announced it would consider raising funds in a meeting on December 1, 2025.
 
At 11:10 AM, NACL Industries’ share price was trading 4.98 per cent higher at ₹196.1 per share on BSE. In comparison, the BSE Sensex was up 0.48 per cent at 86,021.89.
 
The company has a total market capitalisation of ₹3,949.94 crore. Its 52-week high was at ₹337.65 and 52-week low was at ₹50. 
“A meeting of the Board of Directors of NACL Industries Limited (Company) is scheduled to be held on Monday, December 1, 2025, inter-alia, to consider and evaluate a proposal for raising funds, including by way of a rights issue, preferential allotment, qualified institutional placement, or any other permissible mode and for combination thereof, through the issuance of equity shares, equity-linked securities, warrants, and for any other eligible securities,” the filing read.  ALSO READ | Why did Patel Engineering share zoom 16% in trade today? Find out here 
That apart, in Q2, NACL Industries posted a net profit of ₹2.55 crore, as compared to ₹14.9 crore year-on-year (Y-o-Y). The company’s revenue from operations stood at ₹456.9 crore, as against ₹443.69 crore a year ago. The company’s total expenses stood at ₹433 crore, as compared to ₹423.58 crore a year ago. 
 
NACL Industries is an agrochemical company, focused on improving agricultural productivity and sustainability. The company serves both domestic and international markets with a broad portfolio of crop protection products, including insecticides, fungicides, herbicides, plant growth regulators and nematicides, as well as key technical-grade active ingredients such as acetamiprid, amitraz, carbendazim and imidacloprid.
 
NACL operates technical manufacturing plants at Srikakulam in Andhra Pradesh and Dahej in Gujarat, supported by two formulation units at Ethakota in East Godavari, Andhra Pradesh, and a dedicated research and development centre in Rangareddy, Telangana. The company emphasises integrity, quality and a collaborative, performance-driven culture as it works to support modern farming practices. 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :NACL IndustriesBuzzing stocksstock market tradingBSE SensexNSE NiftyNifty50

First Published: Nov 27 2025 | 11:28 AM IST

Next Story